Loading...
XNAS
ZYBT
Market cap36mUSD
Jul 09, Last price  
0.77USD
1D
0.13%
1Q
-27.17%
IPO
-82.84%
Name

Zhengye Biotechnology Holding Ltd

Chart & Performance

D1W1MN
XNAS:ZYBT chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
116m
-37.56%
214,067,000260,269,000211,651,000186,356,000116,362,000
Net income
-70m
L
38,959,00046,735,00031,457,00011,311,000-69,784,000
CFO
13m
-67.52%
31,807,00017,335,00048,184,00041,046,00013,333,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
IPO date
Jan 07, 2025
Employees
Domiciled in
CN
Incorporated in
KY

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT